Tubize Fin Financials
| TUB Stock | EUR 141.60 0.20 0.14% |
Tubize |
Tubize Fin Stock Summary
Tubize Fin competes with Groep Brussel, Ackermans Van, Tessenderlo, Sofina Socit, and GIMV NV. Financire de Tubize S.A., through its interest in UCB, operates as a biopharmaceutical company worldwide. The companys products in pipeline include UCB0942 for drug resistant epilepsy UCB3491 for infantile epilepsy UCB0599 for Parkinsons disease UCB7858UCB0159 for auto-inflammatory diseases UCB6673 to treat immunological diseases UCB4144VR942 to treat asthma seletalisib for treating Sjrgens syndrome dapirolizumab pegol for systemic lupus erythematosus bimekizumab to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis rozanolixizumab to treat immune thrombocytopenia and myasthenia gravis and romosozumab for post-menopausal osteoporosis and osteoporosis in men. TUBIZE FIN operates under Pharmaceuticals And Biosciences classification in Belgium and is traded on Brussels Stock Exchange.| Foreign Associate | Germany |
| Instrument | Belgium Stock View All |
| Exchange | Euronext Brussels |
| ISIN | BE0003823409 |
| Business Address | Allee de la |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.financiere-tubize.be |
| Phone | 32 497 51 52 08 |
| Currency | EUR - Euro |
You should never invest in Tubize Fin without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Tubize Stock, because this is throwing your money away. Analyzing the key information contained in Tubize Fin's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Tubize Fin Key Financial Ratios
There are many critical financial ratios that Tubize Fin's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Tubize Fin reports annually and quarterly.| Return On Equity | 0.0988 | |||
| Return On Asset | -3.0E-4 | |||
| Target Price | 77.0 | |||
| Number Of Employees | 12 | |||
| Beta | 0.48 |
Tubize Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tubize Fin's current stock value. Our valuation model uses many indicators to compare Tubize Fin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tubize Fin competition to find correlations between indicators driving Tubize Fin's intrinsic value. More Info.Tubize Fin is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tubize Fin's earnings, one of the primary drivers of an investment's value.Tubize Fin Systematic Risk
Tubize Fin's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tubize Fin volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Tubize Fin correlated with the market. If Beta is less than 0 Tubize Fin generally moves in the opposite direction as compared to the market. If Tubize Fin Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tubize Fin is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tubize Fin is generally in the same direction as the market. If Beta > 1 Tubize Fin moves generally in the same direction as, but more than the movement of the benchmark.
Tubize Fin March 20, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tubize Fin help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tubize Fin. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tubize Fin based on widely used predictive technical indicators. In general, we focus on analyzing Tubize Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tubize Fin's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.54 | |||
| Information Ratio | 0.0673 | |||
| Maximum Drawdown | 15.49 | |||
| Value At Risk | (2.75) | |||
| Potential Upside | 3.2 |
Additional Tools for Tubize Stock Analysis
When running Tubize Fin's price analysis, check to measure Tubize Fin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tubize Fin is operating at the current time. Most of Tubize Fin's value examination focuses on studying past and present price action to predict the probability of Tubize Fin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tubize Fin's price. Additionally, you may evaluate how the addition of Tubize Fin to your portfolios can decrease your overall portfolio volatility.